New NCI Funding Opportunities Are Available! The National Cancer Institute Small Business Innovation Research (SBIR) Program has announced 16 new funding opportunities in a range of novel technology areas. These funding opportunities are available to small businesses to support research and development of: anti-cancer agents biomarkers nanotechnology proteomics pharmacodynamics and many other areas of interest [...]

• 211http://clsdf.com/2007/08/hey-colorado-researchers/Hey+Colorado+Researchers%212007-08-30+05%3A38%3A00admin

Based on the French Café Philosophique…at the Colorado Café Scientifique, people (often science buffs) come together in a friendly pub after work and hear an informal introduction to an interesting current scientific topic led by an expert. We take a short break for refreshments, to meet new people, and chat, and then we return for [...]

• 210http://clsdf.com/2007/08/colorado-cafe-scientifique-sept-mtg/Colorado+Caf%C3%A9+Scientifique%3A+Sept.+Mtg.2007-08-28+00%3A17%3A00admin

Don’t miss the next Holland and Hart Bioentrepreneur Club on Thursday 6 September (7:15am – 9:00am) networking event and discussion featuring Dave Allen, Associate VP for Technology Transfer at the University of Colorado who will be addressing: FY ’06 – ’07 CU TTO performance Bioscience goals for FY ‘08 Evolving early-stage biobusiness infrastructure The CU [...]

• 209http://clsdf.com/2007/08/bioentrepreneur-club-tech-transfer-cu/Bioentrepreneur+Club%3A+Tech+Transfer+%40+CU2007-08-27+14%3A40%3A00admin

Then start with this class! Introduction to Life Science Technology Transfer. This course examines the process of technology transfer in the academic, government laboratory and corporate setting. The focus of the course, from the discovery stage to building the business case, will be on the process of creating innovation from inventions, protecting the innovation and [...]

• 208View 1 Comment...http://clsdf.com/2007/08/want-to-start-a-biotech-company/Want+To+Start+A+Biotech+Company%3F2007-08-27+03%3A40%3A00admin

Wow…Denise Brown, Executive Director of the Colorado BioScience Association just informed me that a link to CLSDF has been placed on the CBSA home page; without a doubt the most prominent link-back this blog has received. Perhaps too some validation of the content being produced here. The team at CBSA is doing incredible work of [...]

• 207http://clsdf.com/2007/08/infinite-loop%e2%80%a6infinite-appreciation/Infinite+Loop%E2%80%A6Infinite+Appreciation%212007-08-24+14%3A01%3A00admin

Last week was the right time at the right place for a meeting at the beautiful new BaroFold offices where I was afforded an opportunity to watch a doe enjoy an afternoon snack of some apples right off the tree.

• 206http://clsdf.com/2007/08/right-place-at-the-right-time/Right+Place+at+the+Right+Time2007-08-21+16%3A55%3A00admin

The Fitzsimons Life Science District had dirt but now has roads. Here I plan to document the growth of the FLSD and will aggregate photos of the emergence and growth on my Flickr account. Check in periodically to observe the progress as a 160-acre bioscience park comes to life…WARNING! Hard Hat Required! Click (here) for [...]

• 205http://clsdf.com/2007/08/in-the-beginning/In+The+Beginning...2007-08-21+16%3A26%3A00admin

Congratulations to Lee Taylor, Billi Cusick and the entire TheraTogs family on their successful appearance yesterday on Fox News 31. Telluride-based TheraTogs developed a live-in exo-muscular system for neuro-motor and postural training. For diseases such as cerebral palsy, multiple sclerosis, Down’s syndrome, spina bifida as well as other segments such as geriatrics (e.g. osteoporosis management) [...]

• 204http://clsdf.com/2007/08/theratogs%e2%84%a2-fox-news-appearance/TheraTogs%E2%84%A2+Fox+News+Appearance2007-08-21+15%3A22%3A00admin

…That is because I am addicted to Twitter, a micro-blogging tool, more specifically it is Tiny Twitter that has stolen my heart, a mobile application that allows me to use Twitter on my Blackberry 8700c. I plan to be micro-blogging throughout the day at tomorrow’s CBSA’s Medical Device Symposium (more info on there here, sign [...]

• 203http://clsdf.com/2007/08/my-name-is-adam-and-i%e2%80%99m-a-twitter-holic%e2%80%a6/My+Name+is+Adam+and+I%E2%80%99m+a+Twitter-holic%E2%80%A62007-08-21+15%3A09%3A00admin

Congratulations to Woody Emlen and the rest of the Taligen Therapeutics team on their excellent Emerging Company Profile appearing in yesterday’s BioCentury’s Bernstein Report on BioBusiness. Great coverage not only for Taligen but this widely distributed periodical shines a great light upon Colorado life sciences. “Taligen Therapeutics, Inc. is taking a two approaches to modulating [...]

• 202http://clsdf.com/2007/08/taligen-featured-in-biocentury/Taligen+Featured+in+BioCentury2007-08-14+21%3A23%3A00admin

Array BioPharma, Inc. (NASDAQ: ARRY) plans to initiate a Phase I trial this fall for ARRY-380, a selective, orally-active ErbB-2 inhibitor for metastatic breast cancer patients and perhaps those who are resistant to Genentech’s (NYSE: DNA) HER2 targeting blockbuster Herceptin. The ARRY-380 candidate ErbB-2 inhibitor has shown efficacy and is well-tolerated in pre-clinical models of [...]

• 201http://clsdf.com/2007/08/arry-380-to-advance-into-human-pi-trial/ARRY-380+To+Advance+Into+Human+PI+Trial2007-08-14+21%3A16%3A00admin

The Fitzsimons Redevelopment Authority invites you to participate in the BioScramble golf tournament and reception on 27 September at the Fitzsimons Golf Course. Free green fees! First foursome tee off @ 2:00pm and reception at the clubhouse begins at 6:00pm. Contact Vicki Jenings (vjenings@colobio.com or 720.859.4108) to sign up or for more information.

• 200http://clsdf.com/2007/08/4-don%e2%80%99t-miss-the-bioscramble/4%21%21%21+Don%E2%80%99t+Miss+the+BioScramble2007-08-14+21%3A10%3A00admin

Continuing the literary theme for a bit… When Jeff Bojar attorney extraordinaire at Snell & Wilmer passed along his recent review of Marc Zimmer’s Glowing Genes: A Revolution in Biotechnology I was quickly transported to a time when I was helping to create a series of Plakoglobin deletion mutants to be used for experiments in [...]

• 199http://clsdf.com/2007/08/an-illuminating-review/An+Illuminating+Review2007-08-08+06%3A01%3A00admin